By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


InVivoScribe Technologies, Inc. 

6330 Nancy Ridge Drive
Suite 106
San Diego  California  92121-3230  U.S.A.
Phone: 858-623-8105 Fax: 858-623-8109



Company News
InVivoScribe Technologies, Inc. Announces Long-Term Collaboration Agreement With Illumina (ILMN) And Plans Release Of NGS-based IVD Assay Kits 2/14/2017 12:04:38 PM
InVivoScribe Technologies, Inc. Release: German Supreme Court Upholds And Strengthens Invivoscribe FLT3 Patent Position 3/30/2016 10:27:04 AM
InVivoScribe Technologies, Inc. Announces Long-Term Collaboration To Develop Immuno-Oncology Tests With Thermo Fisher Scientific (TMO) 2/11/2016 10:37:25 AM
InVivoScribe Technologies, Inc. Announces Companion Diagnostic Agreement 4/28/2015 11:18:35 AM
InVivoScribe Technologies, Inc. Launches Four CE-Marked NGS-Based LymphoTrack Dx Assays 4/21/2015 12:19:20 PM
InVivoScribe Technologies, Inc. Launches Genection, a New Personalized Molecular Medicine Company Delivering Global Access to the Entire Clinically-Actionable Genetic Test Menu 12/6/2012 9:43:15 AM
Takara Bio Grants Patent License to InVivoScribe Technologies, Inc. for FLT3-ITD Testing in Japan 12/5/2012 9:56:58 AM
InVivoScribe Technologies, Inc. Announces Collaboration Agreement to Develop Companion Diagnostic Test 2/16/2011 8:32:31 AM
TrovaGene, Inc. Announces that its NPM1 Technology is Now Part of Laboratory Corporation of America Holdings (LabCorp) (LH)'s and InVivoScribe Technologies, Inc.'s AML Cancer Testing Services 3/31/2010 11:24:23 AM